Histamine release from mast cells and basophils

Handbook of Experimental Pharmacology

Volumn 241, Issue , 2017, Pages 121-139

  Borriello, Francesco ^a,b   Iannone, Raffaella ^a   Marone, Gianni ^a,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c CNR   (Italy)

Author keywords

Basophil; Degranulation; Histamine; Histamine receptors; Mast cell

Indexed keywords

FC RECEPTOR IIA; FC RECEPTOR IIB; G PROTEIN COUPLED RECEPTOR; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; HISTAMINE H4 RECEPTOR; HISTAMINE RECEPTOR; I KAPPA B KINASE BETA; IMMUNOGLOBULIN E; INTERLEUKIN 3; INTERLEUKIN 33; MAS RELATED G PROTEIN COUPLED RECEPTOR X2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE SYK; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEIN TYROSINE PHOSPHATASE SHP 2; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; STEM CELL FACTOR; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; CYTOKINE;

BASOPHIL; BASOPHIL DEGRANULATION; CHEMOTAXIS; CYTOKINE PRODUCTION; DOWN REGULATION; HISTAMINE RELEASE; HUMAN; IMMUNOBIOLOGY; MAST CELL; MAST CELL DEGRANULATION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UPREGULATION; ANIMAL; HYPERSENSITIVITY; IMMUNE SYSTEM; METABOLISM; PHYSIOLOGY;

ANIMALS; BASOPHILS; CYTOKINES; HISTAMINE; HISTAMINE RELEASE; HUMANS; HYPERSENSITIVITY; IMMUNE SYSTEM; MAST CELLS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 85018368587     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/164_2017_18     Document Type: Chapter

References (141)

1. Akahoshi M, Song CH, Piliponsky AM, Metz M, Guzzetta A, Abrink M, Schlenner SM, Feyerabend TB, Rodewald HR, Pejler G, Tsai M, Galli SJ (2011) Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice. J Clin Invest 121: 4180–4191
2. Aldi S, Takano K, Tomita K, Koda K, Chan NY, Marino A, Salazar-Rodriguez M, Thurmond RL, Levi R (2014) Histamine H4-receptors inhibit mast cell renin release in ischemia/reperfusion via protein kinase C epsilon-dependent aldehyde dehydrogenase type-2 activation. J Pharmacol Exp Ther 349: 508–517
3. Artuc M, Guhl S, Babina M, Unger T, Steckelings UM, Zuberbier T (2011) Mast cell-derived TNF-alpha and histamine modify IL-6 and IL-8 expression and release from cutaneous tumor cells. Exp Dermatol 20: 1020–1022
4. Bachelet I, Munitz A, Moretta A, Moretta L, Levi-Schaffer F (2005) The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells. J Immunol 175: 7989–7995
5. Bachelet I, Munitz A, Levi-Schaffer F (2006) Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a. J Allergy Clin Immunol 117: 1314–1320
6. Bachelet I, Munitz A, Berent-Maoz B, Mankuta D, Levi-Schaffer F (2008) Suppression of normal and malignant kit signaling by a bispecific antibody linking kit with CD300a. J Immunol 180: 6064–6069
7. Best CH, Dale HH, Dudley HW, Thorpe WV (1927) The nature of the vaso-dilator constituents of certain tissue extracts. J Physiol 62: 397–417
8. Borriello F, Granata F, Marone G (2014a) Basophils and skin disorders. J Invest Dermatol 134: 1202–1210
9. Borriello F, Granata F, Varricchi G, Genovese A, Triggiani M, Marone G (2014b) Immunopharmacological modulation of mast cells. Curr Opin Pharmacol 17: 45–57
10. Borriello F, Longo M, Spinelli R, Pecoraro A, Granata F, Staiano RI, Loffredo S, Spadaro G, Beguinot F, Schroeder J, Marone G (2015) IL-3 synergises with basophil-derived IL-4 and IL-13 to promote the alternative activation of human monocytes. Eur J Immunol 45: 2042–2051
11. Brune M, Hansson M, Mellqvist UH, Hermodsson S, Hellstrand K (1996) NK cell-mediated killing of AML blasts: role of histamine, monocytes and reactive oxygen metabolites. Eur J Haematol 57: 312–319
12. Bryce PJ, Mathias CB, Harrison KL, Watanabe T, Geha RS, Oettgen HC (2006) The H1 histamine receptor regulates allergic lung responses. J Clin Invest 116: 1624–1632
13. Buckland KF, Williams TJ, Conroy DM (2003) Histamine induces cytoskeletal changes in human eosinophils via the H (4) receptor. Br J Pharmacol 140: 1117–1127
14. Buhring HJ, Streble A, Valent P (2004) The basophil-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell activation and allergy diagnosis. Int Arch Allergy Immunol 133: 317–329
15. Burde R, Seifert R, Buschauer A, Schultz G (1989) Histamine inhibits activation of human neutrophils and HL-60 leukemic cells via H2-receptors. Naunyn Schmiedeberg’s Arch Pharmacol 340: 671–678
16. Chan CY, John ALS, Abraham SN (2012) Plasticity in mast cell responses during bacterial infections. Curr Opin Microbiol 15: 78–84
17. Clark RA, Gallin JI, Kaplan AP (1975) The selective eosinophil chemotactic activity of histamine. J Exp Med 142: 1462–1476
18. Clark GJ, Ju X, Tate C, Hart DN (2009) The CD300 family of molecules are evolutionarily significant regulators of leukocyte functions. Trends Immunol 30: 209–217
19. Cohen RW, Rosenstreich DL (1986) Discrimination between urticaria-prone and other allergic patients by intradermal skin testing with codeine. J Allergy Clin Immunol 77: 802–807
20. Cowden JM, Zhang M, Dunford PJ, Thurmond RL (2010) The histamine H4 receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation. J Invest Dermatol 130: 1023–1033
21. Daeron M, Jaeger S, Pasquier LD, Vivier E (2008) Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future. Immunol Rev 224: 11–43
22. Dale HH, Laidlaw PP (1910) The physiological action of beta-iminazolylethylamine. J Physiol 41: 318–344
23. Damaj BB, Becerra CB, Esber HJ, Wen Y, Maghazachi AA (2007) Functional expression of H4 histamine receptor in human natural killer cells, monocytes, and dendritic cells. J Immunol 179: 7907–7915
24. de Paulis A, Prevete N, Fiorentino I, Rossi FW, Staibano S, Montuori N, Ragno P, Longobardi A, Liccardo B, Genovese A, Ribatti D, Walls AF, Marone G (2006) Expression and functions of the vascular endothelial growth factors and their receptors in human basophils. J Immunol 177: 7322–7331
25. Detoraki A, Staiano RI, Granata F, Giannattasio G, Prevete N, de Paulis A, Ribatti D, Genovese A, Triggiani M, Marone G (2009) Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects. J Allergy Clin Immunol 123: 1142–1149, 1149.e1–5
26. Eberle JU, Voehringer D (2016) Role of basophils in protective immunity to parasitic infections. Semin Immunopathol 38: 605–613
27. Ezeamuzie CI, Philips E (2000) Histamine H (2) receptors mediate the inhibitory effect of histamine on human eosinophil degranulation. Br J Pharmacol 131: 482–488
28. Feldberg W, Kellaway CH (1937) Liberation of histamine from the perfused lung by snake venoms. J Physiol 90: 257–279
29. Feldberg W, Keogh EV (1937) Liberation of histamine from the perfused lung by staphylococcal toxin. J Physiol 90: 280–287
30. Feldberg W, O’Connor WJ (1937) The liberation of histamine from the perfused lung by peptone. J Physiol 90: 288–295
31. Findlay SR, Lichtenstein LM (1980) Basophil “releasability” in patients with asthma. Am Rev Respir Dis 122: 53–59
32. Frei R, Ferstl R, Konieczna P, Ziegler M, Simon T, Rugeles TM, Mailand S, Watanabe T, Lauener R, Akdis CA, O’Mahony L (2013) Histamine receptor 2 modifies dendritic cell responses to microbial ligands. J Allergy Clin Immunol 132: 194–204
33. Galli SJ, Tsai M (2012) IgE and mast cells in allergic disease. Nat Med 18: 693–704
34. Gantner F, Sakai K, Tusche MW, Cruikshank WW, Center DM, Bacon KB (2002) Histamine h (4) and h (2) receptors control histamine-induced interleukin-16 release from human CD8 (+) T cells. J Pharmacol Exp Ther 303: 300–307
35. Gaudenzio N, Sibilano R, Marichal T, Starkl P, Reber LL, Cenac N, McNeil BD, Dong X, Hernandez JD, Sagi-Eisenberg R, Hammel I, Roers A, Valitutti S, Tsai M, Espinosa E, Galli SJ (2016) Different activation signals induce distinct mast cell degranulation strategies. J Clin Invest 126: 3981–3998
36. Genovese A, Borgia G, Bjorck L, Petraroli A, de Paulis A, Piazza M, Marone G (2003) Immunoglobulin superantigen protein L induces IL-4 and IL-13 secretion from human Fc epsilon RI+ cells through interaction with the kappa light chains of IgE. J Immunol 170: 1854–1861
37. Gibbs BF, Sabato V, Bridts CH, Ebo DG, Ben-Zimra M, Levi-Schaffer F (2012) Expressions and inhibitory functions of CD300a receptors on purified human basophils. Exp Dermatol 21: 884–886
38. Godot V, Arock M, Garcia G, Capel F, Flys C, Dy M, Emilie D, Humbert M (2007) H4 histamine receptor mediates optimal migration of mast cell precursors to CXCL12. J Allergy Clin Immunol 120: 827–834
39. Graham HT, Lowry OH, Wheelwright F, Lenz MA, Parish HH Jr (1955) Distribution of histamine among leukocytes and platelets. Blood 10: 467–481
40. Grant JA, Dupree E, Goldman AS, Schultz DR, Jackson AL (1975) Complement-mediated release of histamine from human leukocytes. J Immunol 114: 1101–1106
41. Gutzmer R, Mommert S, Gschwandtner M, Zwingmann K, Stark H, Werfel T (2009) The histamine H4 receptor is functionally expressed on T (H) 2 cells. J Allergy Clin Immunol 123: 619–625
42. Hata D, Kawakami Y, Inagaki N, Lantz CS, Kitamura T, Khan WN, Maeda-Yamamoto M, Miura T, Han W, Hartman SE, Yao L, Nagai H, Goldfeld AE, Alt FW, Galli SJ, Witte ON, Kawakami T (1998) Involvement of Bruton’s tyrosine kinase in FcepsilonRI-dependent mast cell degranulation and cytokine production. J Exp Med 187: 1235–1247
43. Havard S, Scola AM, Kay LJ, Ishmael SS, MacGlashan DW Jr, Peachell PT (2011) Characterization of syk expression in human lung mast cells: relationship with function. Clin Exp Allergy 41: 378–388
44. Hofstra CL, Desai PJ, Thurmond RL, Fung-Leung WP (2003) Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther 305: 1212–1221
45. Huber M, Gibbs BF (2015) SHIP1 and the negative control of mast cell/basophil activation by supra-optimal antigen concentrations. Mol Immunol 63: 32–37
46. Imamura M, Poli E, Omoniyi AT, Levi R (1994) Unmasking of activated histamine H3-receptors in myocardial ischemia: their role as regulators of exocytotic norepinephrine release. J Pharmacol Exp Ther 271: 1259–1266
47. Imamura M, Seyedi N, Lander HM, Levi R (1995) Functional identification of histamine H3-receptors in the human heart. Circ Res 77: 206–210
48. Imamura M, Lander HM, Levi R (1996) Activation of histamine H3-receptors inhibits carriermediated norepinephrine release during protracted myocardial ischemia. Comparison with adenosine A1-receptors and alpha2-adrenoceptors. Circ Res 78: 475–481
49. Inoue I, Taniuchi I, Kitamura D, Jenkins NA, Gilbert DJ, Copeland NG, Watanabe T (1996) Characteristics of the mouse genomic histamine H1 receptor gene. Genomics 36: 178–181
50. Izawa K, Yamanishi Y, Maehara A, Takahashi M, Isobe M, Ito S, Kaitani A, Matsukawa T, Matsuoka T, Nakahara F, Oki T, Kiyonari H, Abe T, Okumura K, Kitamura T, Kitaura J (2012) The receptor LMIR3 negatively regulates mast cell activation and allergic responses by binding to extracellular ceramide. Immunity 37: 827–839
51. Izawa K, Isobe M, Matsukawa T, Ito S, Maehara A, Takahashi M, Yamanishi Y, Kaitani A, Oki T, Okumura K, Kitamura T, Kitaura J (2014) Sphingomyelin and ceramide are physiological ligands for human LMIR3/CD300f, inhibiting FcepsilonRI-mediated mast cell activation. J Allergy Clin Immunol 133: 270–273.e1–7
52. Jones H, Hargrove L, Kennedy L, Meng F, Graf-Eaton A, Owens J, Alpini G, Johnson C, Bernuzzi F, Demieville J, DeMorrow S, Invernizzi P, Francis H (2016) Inhibition of mast cell-secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2 (/) mice. Hepatology 64: 1202–1216
53. Jutel M, Watanabe T, Klunker S, Akdis M, Thomet OA, Malolepszy J, Zak-Nejmark T, Koga R, Kobayashi T, Blaser K, Akdis CA (2001) Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413: 420–425
54. Karasuyama H, Mukai K, Obata K, Tsujimura Y, Wada T (2011) Nonredundant roles of basophils in immunity. Annu Rev Immunol 29: 45–69
55. Karra L, Levi-Schaffer F (2011) Down-regulation of mast cell responses through ITIM containing inhibitory receptors. Adv Exp Med Biol 716: 143–159
56. Kashem SW, Subramanian H, Collington SJ, Magotti P, Lambris JD, Ali H (2011) G protein coupled receptor specificity for C3a and compound 48/80-induced degranulation in human mast cells: roles of Mas-related genes MrgX1 and MrgX2. Eur J Pharmacol 668: 299–304
57. Kawakami T, Kashiwakura J, Kawakami Y (2014) Histamine-releasing factor and immunoglobulins in asthma and allergy. Allergy Asthma Immunol Res 6: 6–12
58. Kepley CL, Youssef L, Andrews RP, Wilson BS, Oliver JM (1999) Syk deficiency in nonreleaser basophils. J Allergy Clin Immunol 104: 279–284
59. Kern F, Lichtenstein LM (1976) Defective histamine release in chronic urticaria. J Clin Invest 57: 1369–1377
60. Kiwamoto T, Kawasaki N, Paulson JC, Bochner BS (2012) Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions. Pharmacol Ther 135: 327–336
61. Knol EF, Mul FP, Jansen H, Calafat J, Roos D (1991) Monitoring human basophil activation via CD63 monoclonal antibody 435. J Allergy Clin Immunol 88: 328–338
62. Kobayashi T, Tonai S, Ishihara Y, Koga R, Okabe S, Watanabe T (2000) Abnormal functional and morphological regulation of the gastric mucosa in histamine H2 receptor-deficient mice. J Clin Invest 105: 1741–1749
63. Kuehn HS, Swindle EJ, Kim MS, Beaven MA, Metcalfe DD, Gilfillan AM (2008) The phosphoinositide 3-kinase-dependent activation of Btk is required for optimal eicosanoid production and generation of reactive oxygen species in antigen-stimulated mast cells. J Immunol 181: 7706–7712
64. Kumagai H, Oki T, Tamitsu K, Feng SZ, Ono M, Nakajima H, Bao YC, Kawakami Y, Nagayoshi K, Copeland NG, Gilbert DJ, Jenkins NA, Kawakami T, Kitamura T (2003) Identification and characterization of a new pair of immunoglobulin-like receptors LMIR1 and 2 derived from murine bone marrow-derived mast cells. Biochem Biophys Res Commun 307: 719–729
65. Lavens-Phillips SE, MacGlashan DW Jr (2000) The tyrosine kinases p53/56lyn and p72syk are differentially expressed at the protein level but not at the messenger RNA level in nonreleasing human basophils. Am J Respir Cell Mol Biol 23: 566–571
66. Leite-de-Moraes MC, Diem S, Michel ML, Ohtsu H, Thurmond RL, Schneider E, Dy M (2009) Cutting edge: histamine receptor H4 activation positively regulates in vivo IL-4 and IFN-gamma production by invariant NKT cells. J Immunol 182: 1233–1236
67. Lewis T, Grant RT (1924) Vascular reactions of the skin to injury. Part 11. The liberation of histamine-like substance in the injured skin, the underlying cause of factitious urticaria and of wheals produced by burning: and observations upon the nervous control of certain skin reactions. Heart 11: 209–265
68. Lichtenstein LM, Gillespie E (1973) Inhibition of histamine release by histamine controlled by H2 receptor. Nature 244: 287–288
69. Lieberman P, Garvey LH (2016) Mast cells and anaphylaxis. Curr Allergy Asthma Rep 16: 20
70. Liu WL (2014) Histamine H4 receptor antagonists for the treatment of inflammatory disorders. Drug Discov Today 19: 1222–1225
71. MacGlashan DW Jr (2007) Relationship between spleen tyrosine kinase and phosphatidylinositol 50 phosphatase expression and secretion from human basophils in the general population. J Allergy Clin Immunol 119: 626–633
72. MacGlashan D Jr (2010) Expression of CD203c and CD63 in human basophils: relationship to differential regulation of piecemeal and anaphylactic degranulation processes. Clin Exp Allergy 40: 1365–1377
73. MacGlashan D Jr (2012) Marked differences in the signaling requirements for expression of CD203c and CD11b versus CD63 expression and histamine release in human basophils. Int Arch Allergy Immunol 159: 243–252
74. MacGlashan D Jr, Honigberg LA, Smith A, Buggy J, Schroeder JT (2011) Inhibition of IgE-mediated secretion from human basophils with a highly selective Bruton’s tyrosine kinase, Btk, inhibitor. Int Immunopharmacol 11: 475–479
75. Macglashan D Jr, Moore G, Muchhal U (2014) Regulation of IgE-mediated signalling in human basophils by CD32b and its role in syk down-regulation: basic mechanisms in allergic disease. Clin Exp Allergy 44: 713–723
76. Marichal T, Tsai M, Galli SJ (2013a) Mast cells: potential positive and negative roles in tumor biology. Cancer Immunol Res 1: 269–279
77. Marichal T, Starkl P, Reber LL, Kalesnikoff J, Oettgen HC, Tsai M, Metz M, Galli SJ (2013b) A beneficial role for immunoglobulin E in host defense against honeybee venom. Immunity 39: 963–975
78. Marone G, Florio G, Petraroli A, de Paulis A (2001) Dysregulation of the IgE/Fc epsilon RI network in HIV-1 infection. J Allergy Clin Immunol 107: 22–30
79. Marone G, Triggiani M, Genovese A, De Paulis A (2005) Role of human mast cells and basophils in bronchial asthma. Adv Immunol 88: 97–160
80. Marone G, Borriello F, Varricchi G, Genovese A, Granata F (2014) Basophils: historical reflections and perspectives. Chem Immunol Allergy 100: 172–192
81. Masini E, Blandina P, Brunelleschi S, Mannaioni PF (1982) Evidence for H2-receptor-mediated inhibition of histamine release from isolated rat mast cells. Agents Actions 12: 85–88
82. Maurer M, Wedemeyer J, Metz M, Piliponsky AM, Weller K, Chatterjea D, Clouthier DE, Yanagisawa MM, Tsai M, Galli SJ (2004) Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 432: 512–516
83. May CD (1976) High spontaneous release of histamine in vitro from leukocytes of persons hypersensitive to food. J Allergy Clin Immunol 58: 432–437
84. Mazzoni A, Leifer CA, Mullen GE, Kennedy MN, Klinman DM, Segal DM (2003) Cutting edge: histamine inhibits IFN-alpha release from plasmacytoid dendritic cells. J Immunol 170: 2269–2273
85. McNeil BD, Pundir P, Meeker S, Han L, Undem BJ, Kulka M, Dong X (2015) Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature 519: 237–241
86. Meiler F, Zumkehr J, Klunker S, Ruckert B, Akdis CA, Akdis M (2008) In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med 205: 2887–2898
87. Melillo RM, Guarino V, Avilla E, Galdiero MR, Liotti F, Prevete N, Rossi FW, Basolo F, Ugolini C, de Paulis A, Santoro M, Marone G (2010) Mast cells have a protumorigenic role in human thyroid cancer. Oncogene 29: 6203–6215
88. Metz M, Piliponsky AM, Chen CC, Lammel V, Abrink M, Pejler G, Tsai M, Galli SJ (2006) Mast cells can enhance resistance to snake and honeybee venoms. Science 313: 526–530
89. Meyer J, Gorbach AM, Liu WM, Medic N, Young M, Nelson C, Arceo S, Desai A, Metcalfe DD, Komarow HD (2013) Mast cell dependent vascular changes associated with an acute response to cold immersion in primary contact urticaria. PLoS One 8: e56773
90. Mobarakeh JI, Sakurada S, Katsuyama S, Kutsuwa M, Kuramasu A, Lin ZY, Watanabe T, Hashimoto Y, Watanabe T, Yanai K (2000) Role of histamine H (1) receptor in pain perception: a study of the receptor gene knockout mice. Eur J Pharmacol 391: 81–89
91. Mobarakeh JI, Sakurada S, Hayashi T, Orito T, Okuyama K, Sakurada T, Kuramasu A, Watanabe T, Watanabe T, Yanai K (2002) Enhanced antinociception by intrathecallyadministered morphine in histamine H1 receptor gene knockout mice. Neuropharmacology 42: 1079–1088
92. Mommert S, Kleiner S, Gehring M, Eiz-Vesper B, Stark H, Gutzmer R, Werfel T, Raap U (2016) Human basophil chemotaxis and activation are regulated via the histamine H4 receptor. Allergy 71: 1264–1273
93. Moon TC, Befus AD, Kulka M (2014) Mast cell mediators: their differential release and the secretory pathways involved. Front Immunol 5: 569
94. Morgan RK, McAllister B, Cross L, Green DS, Kornfeld H, Center DM, Cruikshank WW (2007) Histamine 4 receptor activation induces recruitment of FoxP3+ T cells and inhibits allergic asthma in a murine model. J Immunol 178: 8081–8089
95. Novak N, Mete N, Bussmann C, Maintz L, Bieber T, Akdis M, Zumkehr J, Jutel M, Akdis C (2012) Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2. J Allergy Clin Immunol 130: 1153–1158.e2
96. O’Mahony L, Akdis M, Akdis CA (2011) Regulation of the immune response and inflammation by histamine and histamine receptors. J Allergy Clin Immunol 128: 1153–1162
97. O’Reilly M, Alpert R, Jenkinson S, Gladue RP, Foo S, Trim S, Peter B, Trevethick M, Fidock M (2002) Identification of a histamine H4 receptor on human eosinophils-role in eosinophil chemotaxis. J Recept Signal Transduct Res 22: 431–448
98. Panula P, Chazot PL, Cowart M, Gutzmer R, Leurs R, Liu WL, Stark H, Thurmond RL, Haas HL (2015) International Union of Basic and Clinical Pharmacology. XCVIII. Histamine receptors. Pharmacol Rev 67: 601–655
99. Patella V, Florio G, Petraroli A, Marone G (2000) HIV-1 gp120 induces IL-4 and IL-13 release from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE. J Immunol 164: 589–595
100. Popielski L (1920) β-Imidazolylathylamin und die Organextrakte Erster Teil: b-Imidazolylathylamin als mechtiger Errezer der Magendrucken. Pfluegers Arch 178: 214–236
101. Riley JF, West GB (1952) Histamine in tissue mast cells. J Physiol 117: 72P–73P
102. Riley JF, West GB (1953) The presence of histamine in tissue mast cells. J Physiol 120: 528–537
103. Rivellese F, Suurmond J, de Paulis A, Marone G, Huizinga TW, Toes RE (2014) IgE and IL-33-mediated triggering of human basophils inhibits TLR4-induced monocyte activation. Eur J Immunol 44: 3045–3055
104. Rivellese F, Suurmond J, Habets K, Dorjee AL, Ramamoorthi N, Townsend MJ, de Paulis A, Marone G, Huizinga TW, Pitzalis C, Toes RE (2015) Ability of interleukin-33-and immune complex-triggered activation of human mast cells to down-regulate monocyte-mediated immune responses. Arthritis Rheumatol 67: 2343–2353
105. Rizk A, Curley J, Robertson J, Raber J (2004) Anxiety and cognition in histamine H3 receptor-/-mice. Eur J Neurosci 19: 1992–1996
106. Rossbach K, Schaper K, Kloth C, Gutzmer R, Werfel T, Kietzmann M, Baumer W (2016) Histamine H4 receptor knockout mice display reduced inflammation in a chronic model of atopic dermatitis. Allergy 71: 189–197
107. Sabato V, Verweij MM, Bridts CH, Levi-Schaffer F, Gibbs BF, De Clerck LS, Schiavino D, Ebo DG (2012) CD300a is expressed on human basophils and seems to inhibit IgE/FcepsilonRIdependent anaphylactic degranulation. Cytometry B Clin Cytom 82: 132–138
108. Sabato V, Boita M, Shubber S, Bridts CH, Shibuya A, De Clerck LS, Falcone FH, Ebo DG (2014) Mechanism of phosphatidylserine inhibition of IgE/FcepsilonRI-dependent anaphylactic human basophil degranulation via CD300a. J Allergy Clin Immunol 134: 734–737.e3
109. Sadek B, Saad A, Sadeq A, Jalal F, Stark H (2016) Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases. Behav Brain Res 312: 415–430
110. Saini SS (2009) Basophil responsiveness in chronic urticaria. Curr Allergy Asthma Rep 9: 286–290
111. Sampson HA, Broadbent KR, Bernhisel-Broadbent J (1989) Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity. N Engl J Med 321: 228–232
112. Schafer B, Piliponsky AM, Oka T, Song CH, Gerard NP, Gerard C, Tsai M, Kalesnikoff J, Galli SJ (2013) Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice. J Allergy Clin Immunol 131: 541–548.e1–9
113. Schneider LA, Schlenner SM, Feyerabend TB, Wunderlin M, Rodewald HR (2007) Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin. J Exp Med 204: 2629–2639
114. Schroeder JT (2011) Basophils: emerging roles in the pathogenesis of allergic disease. Immunol Rev 242: 144–160
115. Schroeder JT, Bieneman AP, Chichester KL, Keet CA, Hamilton RG, MacGlashan DW Jr, Wood R, Frischmeyer-Guerrerio PA (2013) Spontaneous basophil responses in food-allergic children are transferable by plasma and are IgE-dependent. J Allergy Clin Immunol 132: 1428–1431
116. Seifert R, Strasser A, Schneider EH, Neumann D, Dove S, Buschauer A (2013) Molecular and cellular analysis of human histamine receptor subtypes. Trends Pharmacol Sci 34: 33–58
117. Shiraishi Y, Jia Y, Domenico J, Joetham A, Karasuyama H, Takeda K, Gelfand EW (2013) Sequential engagement of FcepsilonRI on mast cells and basophil histamine H (4) receptor and FcepsilonRI in allergic rhinitis. J Immunol 190: 539–548
118. Siraganian RP, Hook WA (1977) Mechanism of histamine release by formyl methioninecontaining peptides. J Immunol 119: 2078–2083
119. Stone KD, Prussin C, Metcalfe DD (2010) Ig E, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 125: S73–S80
120. Subramanian H, Gupta K, Guo Q, Price R, Ali H (2011) Mas-related gene X2 (MrgX2) is a novel G protein-coupled receptor for the antimicrobial peptide LL-37 in human mast cells: resistance to receptor phosphorylation, desensitization, and internalization. J Biol Chem 286: 44739–44749
121. Subramanian H, Gupta K, Lee D, Bayir AK, Ahn H, Ali H (2013) Beta-defensins activate human mast cells via Mas-related gene X2. J Immunol 191: 345–352
122. Takahashi K, Suwa H, Ishikawa T, Kotani H (2002) Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype. J Clin Invest 110: 1791–1799
123. Takeshita K, Sakai K, Bacon KB, Gantner F (2003) Critical role of histamine H4 receptor in leukotriene B4 production and mast cell-dependent neutrophil recruitment induced by zymosan in vivo. J Pharmacol Exp Ther 307: 1072–1078
124. Thurmond RL, Desai PJ, Dunford PJ, Fung-Leung WP, Hofstra CL, Jiang W, Nguyen S, Riley JP, Sun S, Williams KN, Edwards JP, Karlsson L (2004) A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J Pharmacol Exp Ther 309: 404–413
125. Toyota H, Dugovic C, Koehl M, Laposky AD, Weber C, Ngo K, Wu Y, Lee DH, Yanai K, Sakurai E, Watanabe T, Liu C, Chen J, Barbier AJ, Turek FW, Fung-Leung WP, Lovenberg TW (2002) Behavioral characterization of mice lacking histamine H (3) receptors. Mol Pharmacol 62: 389–397
126. Triggiani M, Gentile M, Secondo A, Granata F, Oriente A, Taglialatela M, Annunziato L, Marone G (2001) Histamine induces exocytosis and IL-6 production from human lung macrophages through interaction with H1 receptors. J Immunol 166: 4083–4091
127. Triggiani M, Petraroli A, Loffredo S, Frattini A, Granata F, Morabito P, Staiano RI, Secondo A, Annunziato L, Marone G (2007) Differentiation of monocytes into macrophages induces the upregulation of histamine H1 receptor. J Allergy Clin Immunol 119: 472–481
128. Truta-Feles K, Lagadari M, Lehmann K, Berod L, Cubillos S, Piehler S, Herouy Y, Barz D, Kamradt T, Maghazachi A, Norgauer J (2010) Histamine modulates gammadelta-T lymphocyte migration and cytotoxicity, via Gi and Gs protein-coupled signalling pathways. Br J Pharmacol 161: 1291–1300
129. Varricchi G, Galdiero MR, Marone G, Granata F, Borriello F, Marone G (2016) Controversial role of mast cells in skin cancers. Exp Dermatol 26: 11–17
130. Visciano C, Liotti F, Prevete N, Cali G, Franco R, Collina F, de Paulis A, Marone G, Santoro M, Melillo RM (2015) Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8-Akt-Slug pathway. Oncogene 34: 5175–5186
131. Voehringer D (2012) Basophil modulation by cytokine instruction. Eur J Immunol 42: 2544–2550
132. Vonakis BM, Saini SS (2008) Syk-deficient basophils from donors with chronic idiopathic urticaria exhibit a spectrum of releasability. J Allergy Clin Immunol 121: 262–264
133. Vonakis BM, Vasagar K, Gibbons SP Jr, Gober L, Sterba PM, Chang H, Saini SS (2007) Basophil FcepsilonRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria. J Allergy Clin Immunol 119: 441–448
134. Wada T, Ishiwata K, Koseki H, Ishikura T, Ugajin T, Ohnuma N, Obata K, Ishikawa R, Yoshikawa S, Mukai K, Kawano Y, Minegishi Y, Yokozeki H, Watanabe N, Karasuyama H (2010) Selective ablation of basophils in mice reveals their nonredundant role in acquired immunity against ticks. J Clin Invest 120: 2867–2875
135. Wakahara K, Baba N, Van VQ, Begin P, Rubio M, Ferraro P, Panzini B, Wassef R, Lahaie R, Caussignac Y, Tamaz R, Richard C, Soucy G, Delespesse G, Sarfati M (2012) Human basophils interact with memory T cells to augment Th17 responses. Blood 120: 4761–4771
136. Wang M, Han J, Domenico J, Shin YS, Jia Y, Gelfand EW (2016) Combined blockade of the histamine H1 and H4 receptor suppresses peanut-induced intestinal anaphylaxis by regulating dendritic cell function. Allergy 71: 1561–1574
137. Wechsler JB, Schroeder HA, Byrne AJ, Chien KB, Bryce PJ (2013) Anaphylactic responses to histamine in mice utilize both histamine receptors 1 and 2. Allergy 68: 1338–1340
138. Yanai K, Son LZ, Endou M, Sakurai E, Nakagawasai O, Tadano T, Kisara K, Inoue I, Watanabe T, Watanabe T (1998) Behavioural characterization and amounts of brain monoamines and their metabolites in mice lacking histamine H1 receptors. Neuroscience 87: 479–487
139. Yano H, Wershil BK, Arizono N, Galli SJ (1989) Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell dependent. J Clin Invest 84: 1276–1286
140. Yokoi H, Choi OH, Hubbard W, Lee HS, Canning BJ, Lee HH, Ryu SD, von Gunten S, Bickel CA, Hudson SA, Macglashan DW Jr, Bochner BS (2008) Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement. J Allergy Clin Immunol 121: 499–505.e1
141. Zhu D, Kepley CL, Zhang M, Zhang K, Saxon A (2002) A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation. Nat Med 8: 518–521